Oxidative stress in Alzheimer's disease

[48] Amyloid β-peptide-associated free radical oxidative stress, neurotoxicity, and Alzheimer's disease

Butterfield, D. A., Yatin, S. M., Varadarajan, S., & Koppal, T. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09050-3 · Cited by 99

Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain

Ramassamy, C., Krzywkowski, P., Averill‐Bates, D. A., Lussier‐Cacan, S., Théroux, L., Christen, Y., Davignon, J., & Poirier, J. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00268-0 · Cited by 97

Ceruloplasmin levels in the human superior temporal gyrus in aging and Alzheimer's disease

Connor, J. R., Tucker, P., Johnson, M. J., & Snyder, B. S. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90805-u · Cited by 96

Brain membrane fluidity and lipid peroxidation in Alzheimer's disease

Hajimohammadreza, I., & Brammer, M. J. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90226-y · Cited by 96

Oxidative stress promotes $tau; dephosphorylation in neuronal cells: the roles of cdk5 and PP1

Zambrano, C. A., Egaña, J. T., Núñez, M. T., Maccioni, R. B., & González-Billault, C. E. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.03.007 · Cited by 92

Protective effect of Polygonum multiflorum Thunb on amyloid β-peptide 25-35 induced cognitive deficits in mice

Um, M. Y., Choi, W.-H., Aan, J.-Y., Kim, S.-R., & Ha, T. Y. (2005) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2005.08.054 · Cited by 91

Crosslinking of Apolipoprotein E by Products of Lipid Peroxidation

Montine, T. J., Huang, D. Y., Valentine, W. M., Amaranath, V., Saunders, A. M., Weisgraber, K. H., Graham, D. G., & Strittmatter, W. J. (1996) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199602000-00009 · Cited by 90

Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer’s disease

Kimpara, T., Takeda, A., Yamaguchi, T., Arai, H., Okita, N., Takase, S., Sasaki, H., & Itoyama, Y. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00128-7 · Cited by 90

Increased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down Syndrome and Alzheimer’s disease

Balcz, B., Kirchner, L., Cairns, N. J., Fountoulakis, M., & Lübec, G. (2001) · Springer eBooks · doi:10.1007/978-3-7091-6262-0_15 · Cited by 89

Molecular aspects of aging

FINKELSTEIN, D. B. (1996) · Experimental Gerontology · doi:10.1016/0531-5565(96)00007-1 · Cited by 89

Alzheimer’s disease and total plasma aminothiols

McCaddon, A., Hudson, P. R., Hill, D., Barber, J., Lloyd, A., Davies, G. K., & Regland, B. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01451-8 · Cited by 89

Methionine regulates copper/hydrogen peroxide oxidation products of Aβ

Ali, F. E. A., Separovic, F., Barrow, C. J., Cherny, R. A., Fraser, F. W., Bush, A. I., Masters, C. L., & Barnham, K. J. (2004) · Journal of Peptide Science · doi:10.1002/psc.626 · Cited by 89

Functional Alterations in Alzheimerʼs Disease

Simonian, N. A., & Hyman, B. T. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199311000-00004 · Cited by 89

Plasma levels of 8-epiPGF2α, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer’s disease

Feillet‐Coudray, C., Tourtauchaux, R., Niculescu, M., Rock, E., Tauveron, I., Alexandre-Gouabau, M. C., Rayssiguier, Y., Jalenques, I., & Mazur, A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00096-9 · Cited by 88

Structure of the Alzheimer β‐amyloid peptide (25–35) and its interaction with negatively charged phospholipid vesicles

Martínez-Senac, M. M., Villalaı́n, J., & Gómez-Fernández, J. C. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00775.x · Cited by 88

The genetics of late-onset Alzheimerʼs disease

Myers, A., & Goate, A. (2001) · Current Opinion in Neurology · doi:10.1097/00019052-200108000-00002 · Cited by 88

NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with alzheimer’s disease

Wang, Y., Santa–Cruz, K., DeCarli, C., & Johnson, J. A. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00114-7 · Cited by 87

Blood Activity of Cu/Zn Superoxide Dismutase, Glutathione Peroxidase and Catalase in Alzheimer’s Disease: A Case-Control Study

Nadif, R., Briançon, S., Jeandel, C., Artur, Y., Minn, A., Penin, F., & Siest, G. (2009) · Gerontology · doi:10.1159/000213215 · Cited by 84

Protection against amyloid beta-peptide (1–42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: Implications for Alzheimer's disease

Abdul, H. M., & Butterfield, D. A. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.12.002 · Cited by 82

Gelsolin inhibits the fibrillization of amyloid beta-protein, and also defibrillizes its preformed fibrils

Ray, I., Chauhan, A., Węgiel, J., & Chauhan, V. P. S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02315-x · Cited by 81

Oxidative damage in the olfactory system in Alzheimer's disease

Perry, G. L., Castellani, R. J., Smith, M. A., Harris, P. L. R., Kubat, Z., Ghanbari, K., Jones, P. K., Cordone, G., Tabaton, M., Wolozin, B. L., et al. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0761-7 · Cited by 81

Immunocytochemical evidence that amyloid β (1–42) impairs endogenous antioxidant systems in vivo

Kim, H., Yamada, K., Nitta, A., Olariu, A., Tran, M. H., Mizuno, M., Nakajima, A., Nagai, T., Kamei, H., Jhoo, W., et al. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00993-4 · Cited by 79

Aging‐ and Oxygen‐induced Modifications in Brain Biochemistry and Behaviora

Carney, J. M., Smith, C. D., Carney, A. M., & Butterfield, D. A. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb21788.x · Cited by 79

Lack of glutathione peroxidase-1 exacerbates Aβ-mediated neurotoxicity in cortical neurons

Crack, P. J., Cimdins, K., Ali, U., Hertzog, P. J., & Iannello, R. C. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0352-y · Cited by 79

Cholesterol, oxidative stress, and Alzheimer’s disease: expanding the horizons of pathogenesis1 1This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer’s Disease.” The full list of papers may be found on the homepage of the journal.

Pappolla, M. A., Smith, M. A., Bryant‐Thomas, T., Bazan, N., Petanceska, S. S., Perry, G. L., Thal, L. J., Sano, M., & Refolo, L. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00841-9 · Cited by 78

Ceruoplasmin Is Increased in Cerebrospinal Fluid in Alzheimerʼs Disease but Not Parkinsonʼs Disease

Loeffler, D. A., DeMaggio, A. J., Juneau, P. L., Brickman, C. M., Mashour, G. A., Finkelman, J., Pomara, N., & LeWitt, P. A. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199408030-00005 · Cited by 78

Molecular mechanisms initiating amyloid beta-fibril formation in Alzheimer's disease.

Kirkitadze, M. D., & Kowalska, A. (2005) · Acta Biochimica Polonica · doi:10.18388/abp.2005_3454 · Cited by 77

Peripheral markers of oxidative stress in probable Alzheimer patients

Repetto, Reides, Evelson, P., Kohan, Lustig, D., & Llesuy (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00506.x · Cited by 77

Cytochrome Oxidase Inhibition: A Novel Animal Model of Alzheimer's Disease

Bennett, M. C., Diamond, D. M., Stryker, S. L., Parks, J. K., & Parker, W. D. (1992) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/002383099200500206 · Cited by 77

Alzheimer's disease. The commonest form of amyloidosis.

Glenner, G. G. (1983) · PubMed · Cited by 76

Neurodegenerative mechanisms in alzheimer disease: A role for oxidative damage in amyloid β protein precursor-mediated cell death

Sopher, B. L., Fukuchi, K., Kavanagh, T. J., Furlong, C. E., & Martin, G. M. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02814999 · Cited by 75

Serum levels of β‐carotene, α‐carotene and vitamin A in patients with Alzheimer's disease

Jiménez‐Jiménez, F. J., Molina, J. A., Bustos, F., Pareja, M. O., Benito‐León, J., Tallón-Barranco, A., Gasalla, T., Porta-Etessam, J., & Arenas, J. (1999) · European Journal of Neurology · doi:10.1046/j.1468-1331.1999.640495.x · Cited by 74

Iron in the brain: implications for Parkinson's and Alzheimer's diseases.

Youdim, M. B. H. (1988) · PubMed · Cited by 72

Walnut Extract Inhibits the Fibrillization of Amyloid Beta-Protein, and also Defibrillizes its Preformed Fibrils

Chauhan, N., Wang, K., Węgiel, J., & Malik, M. N. (2004) · Current Alzheimer Research · doi:10.2174/1567205043332144 · Cited by 71

Modulation of Nitric Oxide Production in Human Macrophages by Apolipoprotein-E and Amyloid-Beta Peptide

Vitek, M. P., Snell, J. C., Dawson, H. N., & Colton, C. A. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7408 · Cited by 71

bcl-2 protein expression in aged brain and neurodegenerative diseases

Migheli, A., Cavalla, P., Piva, R., Giordana, M. T., & Schiffer, D. (1994) · Neuroreport · doi:10.1097/00001756-199410000-00016 · Cited by 70

Regional Brain Activity of Free Radical Defense Enzymes in Autopsy Samples from Patients with Alzheimer's Disease and from Nondemented Controls

Chen, L., Richardson, J. S., Caldwell, J. E., & Ang, L. C. (1994) · International Journal of Neuroscience · doi:10.3109/00207459408986291 · Cited by 69

Review: David Oppenheimer Memorial Lecture 1995: Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines*

Wı́sniewski, H. M., Węgiel, J., & Kotula, L. (1996) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1996.tb00839.x · Cited by 68

Increased frequency of the transferrin C2 subtype in Alzheimerʼs disease

van Rensburg, S. J., Carstens, M. E., Potocnik, F. C. V., Aucamp, A. K., & Taljaard, J. J. F. (1993) · Neuroreport · doi:10.1097/00001756-199309000-00015 · Cited by 68

APP and PS-1 mutations induce brain oxidative stress independent of dietary cholesterol: implications for Alzheimer’s disease

Abdul, H. M., Wenk, G. L., Gramling, M., Hauss‐Wegrzyniak, B., & Butterfield, D. A. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.06.077 · Cited by 68

Copper, Ceruloplasmin and Superoxide Dismutase in Patients with Alzheimer’s Disease

Snædal, J., Kristinsson, J., Gunnarsdóttir, S. A., Ólafsdóttir, A., Baldvinsson, M., & Jóhannesson, T. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017067 · Cited by 67

Melatonin prevents free radical formation due to the interaction between β‐amyloid peptides and metal ions [Al(III), Zn(II), Cu(II), Mn(II), Fe(II)]

Zatta, P. F., Tognon, G., & Carampin, P. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00058.x · Cited by 64

Immunohistochemical localization of redox factor-1 (Ref-1) in Alzheimerʼs hippocampus

Tan, Z., Sun, N., & Schreiber, S. S. (1998) · Neuroreport · doi:10.1097/00001756-199808240-00012 · Cited by 64

Concentrations of α-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia

Tohgi, H., Abe, T., Nakanishi, M., Hamato, F., Sasaki, K., & Takahashi, S. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90122-8 · Cited by 64

Non-haem iron histochemistry of the normal and Alzheimer's disease hippocampus.

Morris, C. M., Kerwin, J. M., & Ja, E. (1994) · PubMed · Cited by 61

Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations

Leutner, S., Czech, C., Schindowski, K., Touchet, N., Eckert, A., & Müller, W. E. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01449-x · Cited by 60

Migration of perivascular cells into the neuropil and their involvement in ?-amyloid plaque formation

Wı́sniewski, H. M., & Weigel, J. (1993) · Acta Neuropathologica · doi:10.1007/bf00334667 · Cited by 58

The Frequency of Point Mutations in Mitochondrial DNA Is Elevated in the Alzheimer's Brain

Chang, S.-W., Zhang, D., Chung, H. D., & Zassenhaus, H. P. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2885 · Cited by 58

Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress

Praprotnik, D., Smith, M. A., Richey, P., Vinters, H., & Perry, G. (1995) · Acta Neuropathologica · doi:10.1007/s004010050385 · Cited by 57

AP-1 mediates β-amyloid-induced iNOS expression in PC12 cells via the ERK2 and p38 MAPK signaling pathways

Jang, J.-H., & Surh, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.057 · Cited by 57

Altered mitochondrial membrane fluidity in AD brain

Mecocci, P., Cherubini, A., Beal, M. F., Cecchetti, R., Chionne, F., Polidori, M. C., Romano, G., & Senin, U. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12509-x · Cited by 56

Nitric Oxide Mimetic Molecules as Therapeutic Agents in Alzheimers Disease

Thatcher, G. R. J., Bennett, B. M., & Reynolds, J. N. (2005) · Current Alzheimer Research · doi:10.2174/1567205053585945 · Cited by 56

Oxidative stress induced by beta-amyloid peptide1–42 is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells

Qi, X., Xiu, J., Shan, K.-R., Xiao, Y. C., Gu, R., Liu, R., & Guan, Z.-Z. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.02.007 · Cited by 55

β-Amyloid Peptides Are Cytotoxic to Astrocytes in Culture: A Role for Oxidative Stress

Brera, B., Serrano, A., & CEBALLOS, M. L. D. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0313 · Cited by 55

Untitled work

(2006) · PubMed · Cited by 54

Is a point mutation in the mitochondrial ND2 gene associated with alzheimer's disease?

Petruzzella, V., Chen, X., & Schon, E. A. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(05)80834-4 · Cited by 53

Overexpression of superoxide dismutase 1 protects against β-amyloid peptide toxicity: effect of estrogen and copper chelators

Celsi, F., Ferri, A., Casciati, A., D’Ambrosi, N., Rotilio, G., Costa, A. C., Volonté, C., & Carrì, M. T. (2003) · Neurochemistry International · doi:10.1016/s0197-0186(03)00101-3 · Cited by 52

Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia

Ihara, Y., Hayabara, T., Sasaki, K., Fujisawa, Y., Kawada, R., Yamamoto, T., Nakashima, Y., Yoshimune, S., Kawai, M., Kibata, M., et al. (1997) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00172-x · Cited by 52

Alzheimer's β-amyloid peptide as a source of neurotoxic free radicals: the role of structural effects

Pogocki, D. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1463 · Cited by 51

Oxidative-stress associated parameters (lactoferrin, superoxide dismutases) in serum of patients with Alzheimer's disease

Thome, J., Gsell, W., Rösier, M., Kornhuber, J., Frölich, L., Hashimoto, E., Zielke, B., Wiesbeck, G. A., & Riedcrer, P. (1996) · Life Sciences · doi:10.1016/s0024-3205(96)00583-8 · Cited by 50

A mitochondrial DNA deletion in normally aging and in Alzheimer brain tissue

Blanchard, B. J., Park, T., Fripp, W. J., Lerman, L. S., & Ingram, V. M. (1993) · Neuroreport · doi:10.1097/00001756-199306000-00051 · Cited by 49

Lipid Peroxidation and Nitrite plus Nitrate Levels in Brain Tissue from Patients with Alzheimer’s Disease

Miranda, M. D. C., de Bruin, V. M. S., Vale, M. R., & Viana, G. S. D. B. (2000) · Gerontology · doi:10.1159/000022156 · Cited by 49

Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.

Fernandes, M. A. S., Proenca, M. T., Nogueira, A. J. A., Grazina, M. M., Oliveira, L. M. V., Fernandes, A. I., Santiago, B., Santana, I. J., & Oliveira, C. R. (1999) · International Journal of Molecular Medicine · doi:10.3892/ijmm.4.2.179 · Cited by 48

Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5Y

Gasic‐Milenkovic, J., Loske, C., & Münch, G. W. (2003) · Journal of Alzheimer s Disease · doi:10.3233/jad-2003-5104 · Cited by 47

Determination of Malonaldehyde in Alzheimer’s Disease: A Comparative Study of High-Performance Liquid Chromatography and Thiobarbituric Acid Test

Bermejo‐Bescós, P., Gómez-Serranillos, M. P., Santos, J. V. D. O., Pastor, E., Madrona, P. G., & Martín‐Aragón, S. (2009) · Gerontology · doi:10.1159/000213853 · Cited by 45

11. Molecular genetics of Alzheimer's disease

Hardy, J., Owen, M. J., Goate, A., James, L., Haynes, A. R., Williamson, R., Roques, P. K., Rossor, M. N., & Mullan, M. J. (1989) · Biochemical Society Transactions · doi:10.1007/978-1-4613-0513-2_3 · Cited by 44

Expression of DNA excision-repair-cross-complementing proteins p80 and p89 in brain of patients with Down Syndrome and Alzheimer's disease

Hermon, M., Cairns, N. J., Egly, J., Fery, A., Labudová, O., & Lübec, G. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00488-1 · Cited by 44

8OHdG levels in brain do not indicate oxidative DNA damage in Alzheimer's disease

Koppele, J. M. T., Lucassen, P. J., Sakkee, A. N., Asten, J. G. V., Ravid, R., Swaab, D. F., & van Bezooijen, C. F. A. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00165-0 · Cited by 44

No Association of Mutations at Nucleotide 5460 of Mitochondrial NADH Dehydrogenase with Alzheimer′s Disease

Kösel, S., Egensperger, R., Mehraein, P., & Graeber, M. B. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2245 · Cited by 42

Aging, gender and APOE isotype modulate metabolism of Alzheimer's Aβ peptides and F2‐isoprostanes in the absence of detectable amyloid deposits

Yao, J., Petanceska, S. S., Montine, T. J., Holtzman, D. M., Schmidt, S. D., Parker, C. A., Callahan, M. J., Lipinski, W. J., Bisgaier, C. L., Turner, B. A., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02532.x · Cited by 41

Nitric oxide induces tau hyperphosphorylation via glycogen synthase kinase‐3β activation

Zhang, Y.-J., Xu, Y., Liu, Y., Yin, J., & Wang, J. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.09.095 · Cited by 41

The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls

Famulari, A. L., Marschoff, E. R., Llesuy, S., Kohan, S., Serra, J. A., Domínguez, R. O., Repetto, M. G., Reides, C. G., & de Lustig, E. S. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00163-3 · Cited by 40

β-Amyloid 25–35 activates nitric oxide synthase in a neuronal clone

Hu, J., & El‐Fakahany, E. E. (1993) · Neuroreport · doi:10.1097/00001756-199306000-00041 · Cited by 40

β‐Amyloid inhibits NOS activity by subtracting NADPH availability

Venturini, G., Colasanti, M., Persichini, T., Fioravanti, E., Ascenzi, P., Palomba, L., Cantoni, O., & Musci, G. (2002) · The FASEB Journal · doi:10.1096/fj.02-0186fje · Cited by 38

Oxidative Stress in Synaptosomal Proteins from Mutant Presenilin-1 Knock-in Mice: Implications for Familial Alzheimer's Disease

LaFontaine, M., Mattson, M. P., & Butterfield, D. A. (2002) · Neurochemical Research · doi:10.1023/a:1015560116208 · Cited by 38

Up-regulation of Bcl-xL in response to subtoxic β-amyloid: role in neuronal resistance against apoptotic and oxidative injury

Luetjens, C. M., Lankiewicz, S., Bui, N. T., Krohn, A. J., Poppe, M., & Prehn, J. H. M. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00458-9 · Cited by 37

Gossypin protects primary cultured rat cortical cells from oxidative stress- and β-amyloid-lnduced toxicity

Yoon, I., Lee, K. H., & Cho, J. (2004) · Archives of Pharmacal Research · doi:10.1007/bf02980089 · Cited by 37

Isoprenoids in aging and neurodegeneration

Edlund, C., Söderberg, M. P., & Kristensson, K. (1994) · Neurochemistry International · doi:10.1016/0197-0186(94)90050-7 · Cited by 37

Serum levels of coenzyme Q 10 in patients with Alzheimer's disease

de Bustos, F., Molina, J. A., Jiménez-Jiménez, F. J., García‐Redondo, A., Gómez-Escalonilla, C., Porta-Etessam, J., Berbel, Á., Zurdo, M., Barcenilla, B., Parrilla, G., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050019 · Cited by 37

Oxidative stress after acute and chronic application of β-amyloid fragment 25–35 in cortical cultures

Café, C., Torri, C., Bertorelli, L., Angeretti, N., Lucca, E., Forloni, G., & Marzatico, F. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(95)12250-8 · Cited by 37

Alzheimer's Disease: a Pathogenic Role for Aluminosilicate-Induced Phagocytic Free Radicals

Evans, P. H. R., Klinowski, J., Yano, E., & Urano, N. (1989) · Free Radical Research Communications · doi:10.3109/10715768909055157 · Cited by 37

3-Nitrotyrosine immunoreactivity in olfactory receptor neurons of patients with Alzheimer’s disease: implications for impaired odor sensitivity

Getchell, M. L., Shah, D. S., Buch, S. K., Davis, D. G., & Getchell, T. V. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00195-1 · Cited by 36

Transferrin C2 and Alzheimer's disease: Another piece of the puzzle found?

van Rensburg, S. J., Carstens, M. E., Potocnik, F. C. V., van der Spuy, G. D., van der Walt, B. J., & Taljaard, J. J. F. (1995) · Medical Hypotheses · doi:10.1016/0306-9877(95)90178-7 · Cited by 35

Alzheimer's disease, oxidative injury, and cytokines

Summers, W. K. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6609 · Cited by 34

Low Mutational Burden of Individual Acquired Mitochondrial DNA Mutations in Brain

Simon, D. K., Lin, M. T. S., Ahn, C., Liu, G.-J., Gibson, G. E., Beal, M. F., & Johns, D. R. (2001) · Genomics · doi:10.1006/geno.2001.6515 · Cited by 34

Insulysin: An Allosteric Enzyme As a Target for Alzheimer's Disease

Song, E. S., & Hersh, L. B. (2005) · Journal of Molecular Neuroscience · doi:10.1385/jmn:25:3:201 · Cited by 32

Pharmacological Approaches of Neurofibrillary Degeneration

Iqbal, K., & Grundke, I. (2005) · Current Alzheimer Research · doi:10.2174/1567205054367810 · Cited by 31

α1-Trypsin Immunoreactivity in Alzheimer Disease

Smith, M. A., Kalaria, R. N., & Perry, G. L. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1663 · Cited by 28

Alzheimer's disease is not associated with altered concentrations of the nitric oxide synthase inhibitor asymmetric dimethylarginine in cerebrospinal fluid

Mulder, C., Wahlund, L., Blomberg, M. I., de Jong, S., van Kamp, G. J., Scheltens, P., & Teerlink, T. (2002) · Journal of Neural Transmission · doi:10.1007/s00702-002-0760-1 · Cited by 28

Erythrocyte glutathione peroxidase and superoxide dismutase in Alzheimer's disease and other dementias

Sulkava, R. O., Nordberg, U.-R., Erkinjuntti, T., & Westermarck, T. (1986) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1986.tb04590.x · Cited by 28

Normal cerebrospinal fluid glutathione concentrations in Parkinson’s disease, Alzheimer’s disease and multiple system atrophy

Konings, C. H., Kuiper, M. A., Teerlink, T., Mulder, C., Scheltens, P., & Wolters, E. C. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00167-7 · Cited by 28

Comparison of donepezil and memantine for protective effect against amyloid-beta(1–42) toxicity in rat septal neurons

Kimura, M., Komatsu, H., Ogura, H., et al. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.08.036 · Cited by 27

Correlation of oxidative stress and the loss of the nicotinic receptor alpha4 subunit in the temporal cortex of patients with Alzheimer's disease

Yu, W., Nordberg, A. K., Ravid, R., & Guan, Z. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01361-7 · Cited by 26

Response Patterns of EGb 761® in Alzheimer’s Disease: Influence of Neuropsychological Profiles

Bars, P. L. L. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-40456 · Cited by 26

Manganese and Copper-Zinc Superoxide Dismutases in the Human Olfactory Mucosa: Increased Immunoreactivity in Alzheimer's Disease

Kulkarni, A. P., Getchell, T. V., Schmitt, F. A., & Getchell, M. L. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0122 · Cited by 24

Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease

Navarro, J. A., Molina, J. A., Jiménez‐Jiménez, F. J., Benito‐León, J., Pareja, M. O., Gasalla, T., Cabrera‐Valdivia, F., Vargas, C., de Bustos, F., & Arenas, J. (1996) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1996.tb00053.x · Cited by 24

Effect of vitamin E and N-acetylcysteine on phosphatidylserine externalization and induction of coagulation by high-glucose—treated human erythrocytes

Jain, S. K., Palmer, M., & Chen, Y. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90189-0 · Cited by 22

The effect of oxidative stress on accumulation of apolipoprotein E3 and E4 in a cell culture model of β-amyloid angiopathy (CAA)

Mazur‐Kolecka, B., Kowal, D., Sukontasup, T., Dickson, D. W., & Frackowiak, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03026-9 · Cited by 21

?-amyloid protein induces the formation of purine dimers in cellular DNA

Duker, N. J., Sperling, J. M., Soprano, K. J., Druin, D. P., Davis, A., & Ashworth, R. (2001) · Journal of Cellular Biochemistry · Cited by 20

Effect of Oxidative Stress on DNA Damage and β‐Amyloid Precursor Proteins in Lymphoblastoid Cell Lines from a Nigerian Population

Lahiri, D. K., XU, Y., Klaunig, J. E., Baiyewu, O., Ogunniyi, A. O., Hall, K. S., Hendrie, H. C., & Sahota, A. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07848.x · Cited by 16

A comparison of single nucleotide primer extension with mispairing PCR-RFLP in detecting a point mutation

Lin, F. H., & Lin, R. J. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)92332-r · Cited by 15

Fibrillar amyloid β-protein forms a membrane-like hydrophobic domain

Chauhan, V. P. S., Chauhan, A., & Węgiel, J. (2001) · Neuroreport · doi:10.1097/00001756-200103050-00031 · Cited by 15

Effect of cerebrospinal fluid from normal and Alzheimer's patients with different apolipoprotein E phenotypes on in vitro aggregation of amyloid beta-protein

Chauhan, A., Pirttilä, T., Mehta, P. D., Chauhan, V. P. S., & Wísniewski, H. M. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00123-2 · Cited by 15

Trypsin interaction with the senile plaques of Alzheimer disease is mediated by β-protein precursor

Smith, M. A., Dunbar, C. E., Miller, E. J., & Perry, G. L. (1996) · Molecular and Chemical Neuropathology · doi:10.1007/bf02815090 · Cited by 15

Brain ?-Amyloid Accumulation in Transgenic Mice Expressing Mutant Superoxide Dismutase 1

Turner, B. J., Li, Q.-X., Laughton, K. M., Masters, C. L., Lopes, E. C., Atkin, J. D., & Cheema, S. S. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7037-z · Cited by 15

Acid phosphatase activity in senile plaques and cerebrospinal fluid of patients with Alzheimer's disease.

Omar, R., Pappolla, M. A., Argani, I., & Davis, K. L. (1993) · PubMed · Cited by 14

Aggregation of amyloid β-protein as function of age and apolipoprotein E in normal and Alzheimer's serum

Chauhan, A., Pirttilä, T., Chauhan, V. P. S., Mehta, P. D., & Wísniewski, H. M. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(97)00221-9 · Cited by 13

Fibrillar amyloid beta-protein inhibits the activity of high molecular weight brain protease and trypsin

Chauhan, V. P. S., Sheikh, A. M., Chauhan, A., Spivack, W. D., Fenko, M. D., & Malik, M. N. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-7105 · Cited by 11

SOD-1 inhibits FAS expression in cortex of APP transgenic mice

Chen, Z., Duan, R., LePecheur, M., Paly, E., London, J., & Zhu, J. (2005) · APOPTOSIS · doi:10.1007/s10495-005-1879-y · Cited by 11

A Second Look into the Oxidant Mechanisms in Alzheimers Disease

Moreira, P. I., Oliveira, C. R., Santos, M. S., Nunomura, A., Honda, K., Zhu, X., Smith, M. A., & Perry, G. L. (2005) · Current Neurovascular Research · doi:10.2174/1567202053586758 · Cited by 11

Binding of trypsin to fibrillar amyloid beta-protein

Chander, H., Chauhan, A., Węgiel, J., Malik, M. N., Sheikh, A. M., & Chauhan, V. P. S. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.079 · Cited by 11

Media from Rhabdomyosarcoma and Neuroblastoma Cell Cultures Stimulate in Vitro Aggregation and Fibrillization of Amyloid Beta-Protein

Chauhan, A., Chauhan, V. P. S., Rubenstein, R., Węgiel, J., & Wı́sniewski, H. M. (1997) · Neurochemical Research · doi:10.1023/a:1027379926976 · Cited by 9

Cu/Zn superoxide dismutase in patients with non-familial Alzheimer’s disease

Margaglione, M., Garofano, R., Cirillo, F., Ruocco, A., Grandone, E., Vecchione, G., Milan, G., Minno, G. D., Blasi, A. D., & Postiglione, A. (1995) · Aging Clinical and Experimental Research · doi:10.1007/bf03324292 · Cited by 8

Mutations in amyloid precursor protein gene and disease

Brown, J. (1991) · The Lancet · doi:10.1016/0140-6736(91)90262-n · Cited by 7

Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease

Resende, R., Moreira, P. I., Proença, T., Deshpande, A., Busciglio, J., Pereira, C., & Oliveira, C. R. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.03.012 · Cited by 343

Antioxidant activities and phenolics content of eight species of seaweeds from north Borneo

Matanjun, P., Mohamed, S., Mustapha, N. M., Muhammad, K., & Ming, C. H. (2008) · Journal of Applied Phycology · doi:10.1007/s10811-007-9264-6 · Cited by 342

Neuroprotective effect of natural products against Alzheimer’s disease

Essa, M. M., Vijayan, R. K., Castellano-Gonzalez, G., Memon, M. A., Braidy, N., & Guillemin, G. J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0799-9 · Cited by 278

Neuroprotective Strategies for Neurological Disorders by Natural Products: An update

Rehman, M. U., Wali, A. F., Ahmad, A., Shakeel, S., Rasool, S., Ali, R., Rashid, S. M., Madkhali, H., Ganaie, M. A., & Khan, R. (2019) · Current Neuropharmacology · doi:10.2174/1570159x16666180911124605 · Cited by 265

Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease

Bermejo, P., Martín-Aragón, S., Benedí, J., Susín, C., Felici, E., Gil, P., Ribera, J. M., & Villar, Á. M. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.02.002 · Cited by 178